Provider
QP82-18 Pharmacy Benefit Exclusion for Azedra (iobenguane I 131) Intravenous Injection
Program effective Date: Sep 28, 2018
Search Results
Displaying 3001 - 3010 of 3655 results
Provider
QP86-18 Addition of Drug to the Calcitonin Gene-Related Peptide (CGRP) Prior Authorization with Quantity Limit Program
Program effective Date: Nov 14, 2018
Provider
QP70-18 Pharmacy Benefit Exclusion for Alferon N (interferon alpha-n3) and Lanoxin (digoxin) Injection for Minnesota Health Care Programs Subscribers
Program effective Date: Aug 21, 2018
Provider
QP35-17 Implementation of New Utilization Management Platform
Program effective Date: Nov 07, 2017
Provider
QP85-18 Pharmacy Benefit Update - New Drug-Related PA with QL Criteria: Pseudobulbar Affect (PBA)
Program effective Date: Oct 11, 2018
Provider
QP99-18 New FEP Employee Opioid Prescription Requirements
Program effective Date: Nov 28, 2018
Provider
QP66-18 Pharmacy Benefit Update - New Drug-Related Prior Authorization with Quantity Limit Criteria: Noctiva (desmopressin acetate)
Program effective Date: Aug 21, 2018
Provider
QP16-17 Contract Renewal Overlapping with Termination Notices for Interpreter Agencies
Program effective Date: Jul 20, 2017
Provider
QP20-17 Searching Eligibility and Benefits
Program effective Date: Aug 08, 2017
Provider
QP68-18 Site of Care Drug Infusion/Injection Program
Program effective Date: Aug 21, 2018